Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed CFO
Inv. presentation
Quarterly results
Cytosorbents Corp (CTSO) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/03/2022 8-K Quarterly results
08/02/2022 8-K Quarterly results
Docs: "CytoSorbents Reports Second Quarter 2022 Financial and Operational Results PRINCETON, N.J., August 2, 2022 — CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, today reported unaudited financial and operating results for the quarter ended June 30, 2022. Second Quarter 2022 Financial Results",
"CytoSorb® Becomes a Featured Blood Purification Therapy on Fresenius Medical Care Critical Care Platforms"
05/03/2022 8-K Quarterly results
Docs: "U.S. Public Relations Contact:"
11/04/2021 8-K Quarterly results
Docs: "U.S. Public Relations Contact:"
08/03/2021 8-K Quarterly results
08/04/2020 8-K Quarterly results
11/05/2019 8-K Quarterly results
Docs: "U.S. Public Relations Contact: Joshua Berkman"
08/06/2019 8-K Quarterly results
11/07/2018 8-K Quarterly results
Docs: "Public Relations Contact: Joshua Berkman Rubenstein Public Relations 212-805-3055"
03/14/2018 8-K Quarterly results
Docs: "Transcript of the CytoSorbents Corporation Conference Call on March 8, 2018, 4:45 pm EST",
"Public Relations Contact:"
05/12/2017 8-K Quarterly results
Docs: "CytoSorbents Reports First Quarter 2017 Financial Results"
03/09/2017 8-K Form 8-K - Current report
03/15/2016 8-K Quarterly results
Docs: "Transcript of the CytoSorbents Corporation Conference Call on March 9, 2016, 4:45 pm EST",
"CytoSorbents Corporation Presentation",
"Investor Contact:"
05/11/2015 8-K Quarterly results
Docs: "Public Relations Contact:"
04/07/2015 8-K Quarterly results
Docs: "Transcript of the CytoSorbents Corporation Conference Call on March 31, 2015, 4:15 pm EST",
"CytoSorbents Corporation Presentation",
"Public Relations Contact: Melanie Sollid-Penton The Ruth Group 646-536-7023 [email protected]",
"Lee Roth The Ruth Group 646-536-7012 [email protected] Public Relations Contact: Melanie Sollid-Penton The Ruth Group 646-536-7023 [email protected]"
05/19/2014 8-K Quarterly results
Docs: "Transcript of the CytoSorbents Corporation Conference Call on May 14, 2014, 4:15pm EST",
"CytoSorbents Corporation Presentation",
"CYTOSORBENTS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Three months ended March 31, 2014 2013 Revenue: Sales $ 569 $ 176 Grant income 491 195 Other revenue 2 --- Total revenue 1,062 371 Cost of revenue 662 253 Gross margin 400 118 Other expenses: Research and development 237 704 Legal, financial and other consulting 310 223 Selling, general and administrative 1,007 613 Total expenses 1,554 1,540 Loss from operations Other /expense: Interest expense/, net 137 207 Change in warrant liability --- Total other /expense, net 207 Loss before benefit from income taxes Benefit from income taxes — — Net loss Preferred stock dividend 1,115 586 Net loss available to common shareholders $ $ Basic and diluted net loss per common share $ $ Weighted average num..."
04/04/2014 8-K Quarterly results
Docs: "Transcript of the Conference Call on March 31, 2014, 4:15pm EST (filed herewith)",
"Powerpoint presentation (filed herewith)",
"Investor Contact:"
11/13/2013 8-K Quarterly results
Docs: "Transcript of the Conference Call on November 6, 2013, 4:15pm EST (filed herewith)",
"Powerpoint presentation (filed herewith)",
"CYTOSORBENTS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy